October 18, 2016 — Elekta introduced the Leksell Vantage Stereotactic System, its latest system for very precise neurosurgery, at the European Society for Stereotactic and Functional Neurosurgery (ESSFN) meeting, Sept. 28 – Oct. 1, in Madrid.
Based on the Leksell Stereotactic System, Leksell Vantage addresses the limitations of using metal components during stereotactic magnetic resonance (MR) and computed tomography (CT) imaging. Constructed of a novel epoxy composite, the robust, metal-free head frame design may allow for faster and better stereotactic imaging. This means higher resolution MR imaging of the brain and fewer artifacts introduced in stereotactic CT scanning.
Also important to clinicians is the new stereotactic arc, a surgical positioning device that enables a faster preparation of the sterile field. Target coordinates are easily set between the left and the right brain hemisphere in deep brain stimulation (DBS) lead placements.
Leksell Vantage’s lightweight, open face design is created to improve the patient experience. In addition to making it easier to eat or drink while the frame is on, it has the potential to reduce MR scanning times. It essentially eliminates the risk of device-related skin sensations due to temperature increase during MR scans.
Stereotactic neurosurgery is a specialty often used for DBS implantations, brain biopsies and drug deliveries to delicate brain targets, as well as cranial radiosurgery.
Leksell Vantage Stereotactic System is not yet CE marked or U.S. Food and Drug Administration (FDA) 510(k) cleared and is not available for sale or distribution. It is expected to be available for clinical use in Europe during 2017.
The Leksell Vantage head frame is designed to be compatible with Leksell Gamma Knife Icon in a future release.
For more information: www.elekta.com
March 28, 2024 
